Clinical trials
Observational Cataract trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Unknown status | 14 |
| Recruiting | 9 |
| Active, not recruiting | 6 |
| Not yet recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 11 |
| Wenzhou Medical University | 9 |
| Eye & ENT Hospital of Fudan University | 3 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| Shanghai 10th People's Hospital | 3 |
| Aier School of Ophthalmology, Central South University | 2 |
| Jin Yang | 2 |
| Peking University Third Hospital | 2 |
| Shanghai High Myopia Study Group | 2 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cataract | 52 |
| Astigmatism | 6 |
| Myopia | 3 |
| Conjunctivitis | 2 |
| Diabetes Mellitus | 2 |
| Pterygium | 2 |
| Anticipation, Genetic | 1 |
| Blepharitis | 1 |
| Capsule Opacification | 1 |
| Ectropion | 1 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.